Your browser is no longer supported. Please, upgrade your browser.
Settings
RGEN Repligen Corporation daily Stock Chart
RGEN [NASD]
Repligen Corporation
Index- P/E115.06 EPS (ttm)0.24 Insider Own1.00% Shs Outstand33.14M Perf Week1.63%
Market Cap911.35M Forward P/E45.45 EPS next Y0.61 Insider Trans-5.12% Shs Float33.14M Perf Month18.28%
Income8.00M PEG4.60 EPS next Q0.13 Inst Own92.30% Short Float7.53% Perf Quarter-1.75%
Sales87.80M P/S10.38 EPS this Y13.30% Inst Trans0.06% Short Ratio8.36 Perf Half Y15.01%
Book/sh3.90 P/B7.05 EPS next Y28.72% ROA5.60% Target Price31.75 Perf Year-26.73%
Cash/sh2.10 P/C13.08 EPS next 5Y25.00% ROE6.50% 52W Range20.07 - 39.17 Perf YTD-2.79%
Dividend- P/FCF77.89 EPS past 5Y188.40% ROI7.90% 52W High-29.79% Beta1.30
Dividend %- Quick Ratio5.30 Sales past 5Y25.10% Gross Margin56.40% 52W Low37.02% ATR0.94
Employees168 Current Ratio6.70 Sales Q/Q20.70% Oper. Margin15.00% RSI (14)59.73 Volatility2.77% 3.73%
OptionableYes Debt/Eq0.00 EPS Q/Q-44.60% Profit Margin9.20% Rel Volume0.50 Prev Close27.32
ShortableYes LT Debt/Eq0.00 EarningsAug 04 BMO Payout0.00% Avg Volume298.44K Price27.50
Recom1.80 SMA203.60% SMA509.64% SMA2004.30% Volume150,249 Change0.66%
Feb-22-16Initiated Craig Hallum Buy
Nov-06-15Downgrade Jefferies Buy → Hold
Apr-23-15Reiterated Jefferies Buy $25 → $38
Mar-07-11Downgrade Rodman & Renshaw Mkt Outperform → Mkt Perform
Jun-30-09Initiated Merriman Buy
Jun-12-08Reiterated Rodman & Renshaw Mkt Outperform $11 → $9
Sep-10-07Reiterated Rodman & Renshaw Mkt Outperform $6 → $8
Apr-12-07Reiterated Rodman & Renshaw Mkt Outperform $5 → $6
Jul-01-16 05:23PM  Repligen Corp. Value Analysis (NASDAQ:RGEN) : July 1, 2016
Jun-30-16 08:45AM  Repligen (RGEN) in Focus: Stock Adds 6.9% in Session
08:17AM  Repligen Corp. breached its 50 day moving average in a Bullish Manner : RGEN-US : June 30, 2016
Jun-02-16 07:30AM  Repligen to Present at Jefferies 2016 Healthcare Conference GlobeNewswire
May-31-16 08:32AM  How to Invest in the Life Cycle of a Drug at Motley Fool
May-26-16 02:52PM  Repligen to Participate in 13th Annual Craig-Hallum Institutional Investor Conference GlobeNewswire
08:20AM  3 Stocks That Help Drugmakers Create Billion Dollar Blockbusters at Motley Fool
May-24-16 04:16PM  REPLIGEN CORP Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements and Exhibits
May-20-16 04:05PM  REPLIGEN CORP Files SEC form 8-K, Entry into a Material Definitive Agreement, Other Events, Financial Statements and
May-19-16 08:41AM  Repligen Announces Pricing of $100 Million of 2.125% Convertible Senior Notes due 2021 GlobeNewswire -8.52%
May-18-16 04:20PM  Repligen Announces Proposed Public Offering of $100 Million of Convertible Senior Notes due 2021 GlobeNewswire
May-12-16 05:18PM  REPLIGEN CORP Files SEC form 8-K, Entry into a Material Definitive Agreement, Submission of Matters to a Vote of Secu
May-10-16 12:48PM  Repligen Corp. :RGEN-US: Earnings Analysis: Q1, 2016 By the Numbers
May-05-16 05:13PM  Edited Transcript of RGEN earnings conference call or presentation 5-May-16 12:30pm GMT
03:37PM  Repligen tops 1Q revenue forecasts
08:56AM  Repligen Corp. breached its 50 day moving average in a Bearish Manner : RGEN-US : May 5, 2016
07:50AM  REPLIGEN CORP Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits
07:30AM  Repligen Reports First Quarter 2016 Financial Results GlobeNewswire
07:07AM  Q1 2016 Repligen Corp Earnings Release - Before Market Open
Apr-29-16 04:51PM  REPLIGEN CORP Files SEC form 8-K, Change in Directors or Principal Officers EDGAR Online
11:24AM  Repligen to Report First Quarter 2016 Financial Results GlobeNewswire
08:26AM  The Biggest Threat to Repligen Stock at Motley Fool
Apr-04-16 04:09PM  Read This Before You Sell Repligen Corporation Stock at Motley Fool
07:44AM  REPLIGEN CORP Files SEC form 8-K, Unregistered Sale of Equity Securities, Regulation FD Disclosure, Other Events, Fin
07:30AM  Repligen Acquires Atoll GmbH GlobeNewswire
Mar-31-16 08:46AM  Repligen Forms Scientific Advisory Board GlobeNewswire
Mar-21-16 08:19AM  Repligen Corp. breached its 50 day moving average in a Bearish Manner : RGEN-US : March 21, 2016
Mar-10-16 01:55PM  ETFs with exposure to Repligen Corp. : March 10, 2016
Mar-07-16 12:54PM  Repligen Corp. :RGEN-US: Earnings Analysis: Q4, 2015 By the Numbers
Mar-06-16 10:07AM  Repligen Corporation Jumped 14.6% in February -- Here's Why at Motley Fool
Mar-02-16 01:04PM  REPLIGEN CORP Financials
Feb-25-16 01:42PM  Edited Transcript of RGEN earnings conference call or presentation 25-Feb-16 1:30pm GMT
08:05AM  Repligen tops 4Q revenue forecasts
08:02AM  REPLIGEN CORP Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits
07:30AM  Repligen Reports Fourth Quarter and Year 2015 Financial Results GlobeNewswire
07:07AM  Q4 2015 Repligen Corp Earnings Release - Before Market Open
Feb-24-16 05:19PM  REPLIGEN CORP Files SEC form 8-K, Entry into a Material Definitive Agreement, Regulation FD Disclosure, Financial Sta
04:59PM  Repligen Announces Extension of Long Term Supply Agreement for Protein A GlobeNewswire
Feb-23-16 03:00PM  Cabillys last stand: The newest challenge to biotechs biggest patent at bizjournals.com
08:22AM  Repligen Corp. breached its 50 day moving average in a Bullish Manner : February 23, 2016
Feb-22-16 07:39AM  Coverage initiated on Repligen by Craig Hallum +5.73%
Feb-17-16 07:30AM  Repligen to Report Fourth Quarter and Full Year 2015 Financial Results GlobeNewswire
Jan-20-16 04:59PM  8 Stocks Moving In Wednesday's After-Hours Session +12.38%
Dec-30-15 04:41PM  Why These Four Stocks Are Moving In Wednesday's After-Hours Session
Dec-29-15 09:03AM  Why You Shouldn't Bet Against Repligen (RGEN) Stock
Dec-21-15 09:26AM  Repligen Corp. breached its 50 day moving average in a Bullish Manner : December 21, 2015
Dec-16-15 10:04AM  Repligen Corp. Value Analysis (NASDAQ:RGEN) : December 16, 2015
Dec-15-15 01:01PM  Repligen Corp. Earnings Analysis: Q3, 2015 By the Numbers
Dec-14-15 02:53PM  Here are the 20 top-performing stocks in Mass. for 2015 at bizjournals.com
Dec-09-15 09:20AM  Repligen Corp. breached its 50 day moving average in a Bullish Manner : December 9, 2015 -5.61%
Dec-04-15 09:55AM  What Biogens sudden cash spike could say about potential acquisitions at bizjournals.com
Nov-24-15 09:11AM  Here Is What Hedge Funds Think About Repligen Corporation (RGEN) at Insider Monkey
Nov-11-15 07:30AM  Repligen to Present at the Stifel 2015 Healthcare Conference GlobeNewswire
Nov-09-15 09:55AM  Repligen Corp. breached its 50 day moving average in a Bearish Manner : November 9, 2015
Nov-06-15 01:49PM  Why Repligen Corporation Shares Are Falling at Motley Fool -17.20%
Nov-05-15 04:13PM  Edited Transcript of RGEN earnings conference call or presentation 5-Nov-15 1:30pm GMT -6.98%
08:25AM  Repligen tops 3Q revenue forecasts
07:55AM  REPLIGEN CORP Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits
07:30AM  Repligen Reports Third Quarter 2015 Financial Results GlobeNewswire
07:07AM  Q3 2015 Repligen Corp Earnings Release - Before Market Open
Oct-22-15 06:20PM  CORRECTION -- Repligen to Report Third Quarter 2015 Financial Results GlobeNewswire
07:30AM  Repligen to Report Third Quarter 2015 Financial Results GlobeNewswire
Oct-19-15 09:30AM  Repligen, DeVry Education, International Business Machines, Fiserv and Apple highlighted as Zacks Bull and Bear of the Day
09:01AM  Bull of the Day: Repligen (RGEN)
Sep-28-15 02:15PM  ETFs with exposure to Repligen Corp. : September 28, 2015 -6.64%
10:32AM  Repligen Corp. breached its 50 day moving average in a Bearish Manner : September 28, 2015
Sep-24-15 08:10AM  Wednesday's After-Hours Movers: 10 Stocks To Watch
Sep-17-15 01:34PM  ETFs with exposure to Repligen Corp. : September 17, 2015
10:22AM  Repligen Corp. breached its 50 day moving average in a Bearish Manner : September 17, 2015
Sep-16-15 09:30AM  The Zacks Analyst Blog Highlights: VIVUS, Regeneron Pharmaceuticals, Gilead Sciences, Repligen and Affymetrix
Sep-15-15 11:36AM  Biotech Poised to Rebound: 5 Growth Picks
08:41AM  REPLIGEN CORP Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and Exhibits
07:30AM  Repligen Appoints Glenn P. Muir to Board of Directors GlobeNewswire
Aug-25-15 08:55AM  Is Repligen (RGEN) an Incredible Growth Stock? 3 Reasons Why It Will Be Tough to Beat
Aug-08-15 08:10PM  10-Q for Repligen Corp. at Company Spotlight
Aug-06-15 12:49PM  Edited Transcript of RGEN earnings conference call or presentation 6-Aug-15 12:30pm GMT
10:07AM  Repligen posts 2Q profit
07:51AM  REPLIGEN CORP Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits
07:30AM  Repligen Reports Second Quarter 2015 Financial Results GlobeNewswire
07:07AM  Q2 2015 Repligen Corp Earnings Release - Before Market Open
Aug-04-15 11:45AM  After 240% Gain, Is Repligen Stock Still a Buy? at Motley Fool
Jul-29-15 07:30AM  Repligen to Report Second Quarter 2015 Financial Results GlobeNewswire
Jul-21-15 02:15PM  Its earnings season: Here are 9 local biotech firms that are actually making a profit at bizjournals.com -6.54%
Jun-30-15 03:15PM  Market sends a message: Cash is king at MarketWatch
Jun-29-15 06:33PM  IBD Market Wrap - 06/29/15
Jun-26-15 05:07AM  Edited Transcript of RGEN presentation 3-Jun-15 12:00pm GMT
May-26-15 01:00PM  Repligen to Present at Jefferies 2015 Healthcare Conference GlobeNewswire
May-22-15 07:56AM  REPLIGEN CORP Files SEC form 8-K, Submission of Matters to a Vote of Security Holders
May-16-15 09:10AM  Very High-Profile Insider Selling Marks Roller-Coaster Market Week at 24/7 Wall St.
May-13-15 11:39AM  Why Danaher's Purchase of Pall Means More M&A is on the Way at Barrons.com
May-10-15 08:11PM  10-Q for Repligen Corp. at Company Spotlight
May-08-15 03:51PM  REPLIGEN CORP Files SEC form 10-Q, Quarterly Report
May-07-15 10:58AM  Repligen posts 1Q profit +17.42%
08:47AM  Repligen Reports First Quarter 2015 Financial Results at noodls
07:47AM  REPLIGEN CORP Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits
07:30AM  Repligen Reports First Quarter 2015 Financial Results GlobeNewswire
07:07AM  Q1 2015 Repligen Corp Earnings Release - Before Market Open
May-03-15 08:13PM  10-K for Repligen Corp. at Company Spotlight
May-01-15 02:35PM  Biotech execs remember MIT professor: He inspired so many scientists at bizjournals.com +6.71%
Apr-29-15 08:01AM  Repligen to Report First Quarter 2015 Financial Results at noodls
Repligen Corporation, a bioprocessing company, focuses on the development, production, and commercialization of products used in the production of monoclonal antibodies, recombinant proteins, and vaccines. It manufactures various forms of Protein A, a critical reagent used to purify monoclonal antibodies. The company also supplies various growth factor alternating tangential flow system and cell filtration products, which are used to increase cell culture productivity during the bioproduction process. In addition, it manufactures and sells OPUS pre-packed chromatography columns, protein A affinity ligands, a critical component of protein A media that is used to separate and purify monoclonal antibody therapeutics. Further, the company has a portfolio of therapeutic product candidates, which include histone deacetylase inhibitor for the treatment of Friedreich's ataxia disease; and RG1068, a synthetic human hormone developed as a novel imaging agent for the detection of pancreatic duct abnormalities in combination with magnetic resonance imaging in patients with pancreatitis and other pancreatic diseases. Additionally, it offers alternating tangential flow system, a filtration device used to improve product yield during the fermentation step of the biologic drug manufacturing process. The company sells its bioprocessing products directly and through distributors to various life sciences companies, biopharmaceutical companies, and contract manufacturers in the United States, the United Kingdom, Sweden, and internationally. Repligen Corporation was founded in 1981 and is headquartered in Waltham, Massachusetts.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
RYAN THOMAS F JRDirectorJun 30Sale26.605,000133,01012,094Jul 01 04:06 PM
RYAN THOMAS F JRDirectorJun 28Option Exercise3.225,00016,10027,094Jun 29 02:46 PM
RYAN THOMAS F JRDirectorJun 28Sale24.5910,000245,88817,094Jun 29 02:46 PM
DAWES KAREN ADirectorJun 27Option Exercise3.1015,00046,50057,746Jun 28 04:40 PM
Benjamin HowardVP Business DevelopmentMay 24Option Exercise6.2310,00062,30028,626May 26 03:31 PM
Benjamin HowardVP Business DevelopmentMay 11Sale26.722,88977,19918,626May 13 03:32 PM
Benjamin HowardVP Business DevelopmentNov 19Option Exercise3.335,00016,65016,554Nov 20 02:55 PM